Event-Driven Stocks

Kalaris Therapeutics, Inc.

KLRSNasdaqCompleted

Formerly Allovir, Inc.

IPOInitial public offering — registration (S-1)

Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
State of incorporation
DE
Form
S-1
Filed
July 6, 2020

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.